VNCE compared with PLX: revenue, margins and what each company keeps, and the suppliers and customers both name

VNCEVince Holding Corp.

Mkt capRevenueRevenue

PLXProtalix BioTherapeutics, Inc.

Mkt capRevenueRevenue

Compare

VNCEVince Holding Corp.

PLXProtalix BioTherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VNCE 1

—Saks Globalunlistedcustomer

Shared 0

No shared counterparties.

Only PLX 6

PFEPfizercustomer

—Chiesiunlistedsupplier

—New Zealand Clinical Research (NZCR)unlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Secarna

unlistedsupplier

2 more · PLX chain ›

VNCEVince Holding Corp.

10.64▲+0.42%· post 10.66

Mkt cap$138.1MRevenue$82MQ2 FY26Revenue$300MFY25

PLXProtalix BioTherapeutics, Inc.

2.60▼−0.57%· post 2.60

ClosedOct 30 '26

Mkt cap$208.7MRevenue$20MQ2 FY26Revenue$53MFY25

Compare

ClosedOct 30 '26

VNCEVince Holding Corp.

PLXProtalix BioTherapeutics, Inc.

10.64▲+0.42%post 10.66

Price

2.60▼−0.57%post 2.60

$138.1M

Mkt cap

$208.7M

Q2 FY26$82M

Revenue

$20MQ2 FY26

FY25$300M

Revenue

$53MFY25

VNCE10.64▲+0.42%vsPLX2.60▼−0.57%ClosedOct 30 '26